Troll Busters | GenomeWeb

Troll Busters

In an intellectual property lawsuit filed by Cepheid against Roche, a US district court has stayed a hearing on whether a PCR patent owned by Roche is invalid until the companies finish ongoing arbitration hearings.

Cepheid last week filed suit against Roche seeking to invalidate a pair of PCR patents owned by Roche.

Patent watchdog firm Troll Busters has chosen to abandon its lawsuit against more than a dozen life science companies for false patent marking related to various nucleic acid detection, amplification, and cloning technologies, according to recently filed court documents.

A US district court has dismissed a lawsuit filed earlier this year against more than a dozen life science companies alleging that they falsely marked certain nucleic acid detection, amplification, and cloning technologies as being patented after the relevant patents expired.

The patent reexamination is intended to challenge a larger "PCR patents duopoly" enjoyed by Roche and Life Technologies, according to an associate at the IP firm that initiated the patent reexamination last month.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.